Scientists find the hidden helper that lets cancer cells mass-produce their growth proteins
Researchers at MD Anderson Cancer Center have found that an enzyme called METTL13 acts like a turbocharger inside cancer cells, helping them churn out growth-driving proteins such as KRAS, one of the most common cancer culprits. In laboratory models, blocking the enzyme slowed tumour growth, made KRAS-targeted drugs work better and counteracted drug resistance. The study, published in Nature Cell Biology, points to a fresh drug target for some of the hardest-to-treat cancers.
The upbeat factorfind the factory's foreman and you may finally slow the factory — a new angle on cancers that resist today's drugs.
SDG 3 · Good health and well-being — Mechanism: tech innovation
Explore:
Discovery